Cargando…
Chronotherapy with low-dose modified-release prednisone for the management of rheumatoid arthritis: a review
To date, rheumatoid arthritis (RA) remains a debilitating, life-threatening disease. One major concern is morning symptoms (MS), as they considerably impair the patients’ quality of life and ability to work. MS change in a circadian fashion, resembling the fluctuations of inflammatory cytokines such...
Autores principales: | Beltrametti, Stefano Paolo, Ianniello, Aurora, Ricci, Clara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123661/ https://www.ncbi.nlm.nih.gov/pubmed/27920546 http://dx.doi.org/10.2147/TCRM.S112685 |
Ejemplares similares
-
Low-dose prednisone chronotherapy for rheumatoid arthritis: a randomised clinical trial (CAPRA-2)
por: Buttgereit, Frank, et al.
Publicado: (2013) -
Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis
por: Buttgereit, Frank, et al.
Publicado: (2010) -
Glucocorticoids and chronotherapy in rheumatoid arthritis
por: Cutolo, Maurizio
Publicado: (2016) -
Efficacy and safety of modified-release prednisone in patients with rheumatoid arthritis
por: Krasselt, Marco, et al.
Publicado: (2016) -
Role of methotrexate chronotherapy in collagen-induced rheumatoid arthritis in rats
por: Wang, X., et al.
Publicado: (2016)